Irenic Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Irenic Capital Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-48,751	Closed	-$88.2K	–	24
2023 Q2	$88.2K	Buy	+48,751	New	+$89.1K	0.03%	15

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Irenic Capital Management's PRDS Position: Q3 2023 in Review

Irenic Capital Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 48,751 shares — an estimated $88.2K sold.

Irenic Capital Management first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $88.2K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Irenic Capital Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Irenic Capital Management sold 48,751 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $88.2K.
Irenic Capital Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Irenic Capital Management's Pardes Biosciences, Inc. Common Stock position peaked at $88.2K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Irenic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.